Citations 12

Trends in Academic Rank and Leadership Roles of Male and Female Mohs Surgeons: A Cross-sectional Study

Dermatologic Surgery | July 28, 2025 | Volume: 51 | Issue: 12 | Pages: 1166-1168

10.1097/dss.0000000000004764 | PMID 40720864

Central centrifugal cicatricial alopecia: retrospective case-control study of 54 patients from a tertiary care center

International Journal of Women’s Dermatology | May 1, 2025 | Volume: 11 | Issue: 2 | Pages: e206

10.1097/jw9.0000000000000206 | PMID 40322563

Spiradenocarcinoma Mimicking Basal Cell Carcinoma Incidentally Discovered During Mohs Micrographic Surgery

Dermatologic Surgery | April 8, 2025 | Volume: 51 | Issue: 8 | Pages: 813-815

10.1097/dss.0000000000004637 | PMID 40197612

Reactive nonsexually related acute genital ulcers: A retrospective analysis of the Mayo Clinic experience

Journal of the European Academy of Dermatology and Venereology | January 20, 2025 | Volume: 39 | Issue: 8 | Pages: No page available

10.1111/jdv.20533 | PMID 39829136

Patch Testing in Solid Organ Transplant Recipients: Experience from a Tertiary Medical Center over 13 Years (2010–2022)

Dermatitis® | December 9, 2024 | Volume: 36 | Issue: 3 | Pages: 216-220

10.1089/derm.2024.0331 | PMID 39653361

Abstract: Background: It is generally recommended that patients not be on immunosuppressive medications for patch testing, as these medications may suppress delayed-type hypersensitivity and lead to false negative results. There is a paucity of literature describing organ transplant recipients who underwent patch testing. Objective: The aim of this study is to examine patch testing results in solid organ transplant recipients over a 13-year period at our institution. Methods: We performed a retrospective analysis of patch test data from adult transplant recipients at our institution. Transplant patients who underwent patch testing were identified from a clinical patch test database, and a chart review was conducted. Results: Eighteen patients were included in the study. Patients had received kidney, liver, or heart transplants. Seven patients (38.9%) had at least one positive reaction. The highest reaction rates were seen with methylisothiazolinone (12.5%), methyldibromo glutaronitrile (12.5%), and benzalkonium chloride (10.0%). Limitations included small sample size, data from a tertiary referral center, and retrospective analysis. Conclusions: Liver and kidney transplant recipients displayed allergic reactions during patch testing. Patients may benefit from patch testing even if receiving immunosuppressive therapy, but some reactions may be falsely negative because of immunosuppression.
Histopathologic features in drug‐induced, malignancy‐associated, or idiopathic linear IgA bullous dermatosis: A retrospective comparative cohort study of 65 patients

Journal of Cutaneous Pathology | September 13, 2024 | Volume: 52 | Issue: 4 | Pages: 254-258

10.1111/cup.14714 | PMID 39266265

Soft Pink Plaques at Site of Breast Cancer Vaccination: Challenge

The American Journal of Dermatopathology | April 18, 2024 | Volume: 46 | Issue: 5 | Pages: e29-e30

10.1097/dad.0000000000002682 | PMID 40008804

Soft Pink Plaques at the Site of Breast Cancer Vaccination: Answer

The American Journal of Dermatopathology | April 18, 2024 | Volume: 46 | Issue: 5 | Pages: 320-321

10.1097/dad.0000000000002683 | PMID 40008799

Large Defect Involving the Central Cutaneous and Mucosal Upper Lip

Dermatologic Surgery | February 28, 2024 | Volume: 50 | Issue: 11 | Pages: 1065-1067

10.1097/dss.0000000000004136 | PMID 38416812

Linear IgA bullous dermatosis of childhood: Retrospective single‐center cohort

Pediatric Dermatology | February 20, 2024 | Volume: 41 | Issue: 3 | Pages: 461-464

10.1111/pde.15567 | PMID 38378007

AbstractLinear IgA bullous dermatosis (LABD) is a rare autoimmune blistering disorder impacting children and adults. In this single‐center retrospective chart review of pediatric patients with LABD at a large tertiary referral center, we report the unifying and unique clinical features of 10 pediatric patients. Patients typically presented with the “cluster of jewels” sign (n = 6; 60%), mucous membrane involvement (n = 5; 50%) and had a mean disease duration of 38 months; six patients (60%) required inpatient admission for management of their skin disease, including all five patients who had mucous membrane involvement. Our findings suggest that pediatric LABD may be a disease with high morbidity and may be associated with severe complications when mucous membranes are involved.